baber/WOPTO huggingface dataset:
Patent PT-788572-E (PT)
Inventor: BECK ROLAND
IPC: E02D35/00
Filed: 1996-08-16
Abstract: PCT No. PCT/DE96/01526 Sec. 371 Date Jun. 11, 1997 Sec. 102(e) Date Jun. 11, 1997 PCT Filed Aug. 16, 1996 PCT Pub. No. WO97/07295 PCT Pub. Date Feb. 27, 1997A method for underpinning a building comprises arranging at least one elongated supporting element below and substantially parallel to the foundation of the building. A whole side wall of the building may thus be underpinned in a single operation without unnecessarily weakening the existing underground. By coupling a plurality of elongated supporting elements, a kind of large-surface foundation that securely supports the building can be created. The architectonic substance of very old buildings may thus be preserved in a non-aggressive manner. In addition, the underpinning method can be carried out very quickly and at a relatively low cost.
Patent PT-795615-E (PT)
Inventor: FUCHS RUDOLF
IPC: C21D9/30
Filed: 1997-02-11
Abstract: Inductive surface hardening process for parts of irregular external geometry, especially camshafts for internal combustion engines, with an inductor at least partially surrounding the part. The part (2) moves through a uniform rolling path at constant coupling distance (X) in parallel to the internal contour of the inductor (15). The equipment used is also claimed.
Patent PT-825983-E (PT)
Inventor: ROSSI ARSENIA
IPC: A61P37/06
Filed: 1997-01-22
Abstract: PCT No. PCT/EP97/00368 Sec. 371 Date Oct. 15, 1997 Sec. 102(e) Date Oct. 15, 1997 PCT Filed Jan. 22, 1997 PCT Pub. No. WO97/30029 PCT Pub. Date Aug. 21, 1997The present invention is related to a process for the preparation of 5-[2H-pyrrol-2-ylidene)methyl]-2,2'-bi-1H-pyrrole compounds and an intermediate compound.
Patent PT-932609-E (PT)
Inventor: STACK GARY PAUL
IPC: A61K31/438
Filed: 1997-10-10
Abstract: The compounds of formula (I) wherein X is H2 or O; R<1> is hydrogen, hydroxy, halo, trifluoromethyl, trifluoromethoxy, alkyl, alkoxy, aralkoxy, alkanoyloxy, amino, mono- or di-alkylamino, alkanamido or alkanesulfonamido; Z is defined by formula (II), (III) or (IV) wherein R<2> is hydrogen, alkyl, cycloalkyl, phenyl optionally substituted with R<1> as defined above,  omega -phenylalkyl or  omega -diphenylalkyl, in which the phenyl ring is optionally substituted with R<1> as defined above, or R<2> is naphthyl, indolyl, indazolyl, thienyl, pyridinyl, pyrimidinyl, quinolinyl, benzoisothiazolyl or benzisoxazolyl, each optionally substituted with R<1> as defined above; R<3> is hydrogen and R<4> is hydrogen, 1-benzimidazolyl-2-one, indolyl, benzoisothiazolyl or benzisoxazolyl, each optionally substituted with R<1> as defined above, or R<4> is -Y-Ar, in which Y is C=O, CHOH, or (CH2)m, wherein m is 0 to 4, and Ar is phenyl, optionally substituted with R<1> as defined above; or R<3> and R<4>, taken together with the carbon atom to which they are attached form (V) or (VI) in which R<5> is hydrogen and R<6> is phenyl, naphthyl, thienyl, indolyl, benzoisothiazolyl or benzisoxazolyl, each optionally substituted with R<1> as defined above; or R<5> and R<6>, taken together with the carbon atoms to which they are attached complete a benzene ring optionally substituted with R<1>; or a pharmaceutically acceptable salt thereof; are useful for the treatment of brain dopamine dysregulation.
Patent PT-842431-E (PT)
Inventor: GERLACH GERALD-F
IPC: G01N33/569
Filed: 1997-05-27
Abstract: The invention relates to an immunological testing device for detection of paratuberculosis in affected mammals. Said device contains plastic plates or plastic containers with a hydrophobic surface on which a layer of a lipopolysaccharide antigen or polysaccharide antigen, obtainable from Mycobacterium paratuberculosis and having a molecular weight of 30 to 50 kDa, is formed.
Patent PT-917466-E (PT)
Inventor: GAST MICHAEL JAY
IPC: A61K31/57
Filed: 1997-07-23
Abstract: This invention provides a method of contraception which comprises administering to a female of child bearing age for 23-25 consecutive days, a first phase combination of a progestin at a daily dosage of 40-500  mu g trimegestone, 250  mu g - 4mg dienogest, or 250  mu g - 4mg drospirenone, and an estrogen at a daily dosage equivalent in estrogenic activity to 10-20  mu g ethinyl estradiol for 3-8 days beginning on day 1 of the menstrual cycle, wherein the same dosage of the progestin and estrogen combination is administered in each of the 3-8 days, a second phase combination of a progestin at a daily dosage of 40-500  mu g trimegestone, 250  mu g - 4 mg dienogest, or 250  mu g - 4 mg drospirenone, and an estrogen at a daily dosage equivalent in estrogenic activity to 10-20  mu g ethinyl estradiol, for 4-15 days, beginning on the day immediately following the last day of administration of the first phase combination, wherein the same dosage of the progestin and estrogen combination is administered in each of the 4-15 days, and a third phase combination of a progestin at a daily dosage of 40-500  mu g trimegestone, 250  mu g - 4 mg dienogest, or 250  mu g - 4 mg drospirenone, and an estrogen at a daily dosage equivalent in estrogenic activity to 10-20  mu g ethinyl estradiol, for 4-15 days beginning on the day immediately following the last day of administration of the second phase combination, wherein the same dosage of the progestin and estrogen combination is administered in each of the 4-15 days provided that the daily dosage of the combination administered in the first phase is not the same as the daily dosage of the combination administered in the second phase and that the daily dosage of the combination administered in the second phase is not the same as the daily dosage of the combination administered in the third phase.
Patent PT-968219-E (PT)
Inventor: BAHRMANN HELMUT
IPC: C07F9/50
Filed: 1998-01-14
Abstract: Guanidinium phosphanes of Formula Iwherein the substituents are defined as in the specification which are useful catalyst ligands for the carbon-carbon linkage reactions of the hect reaction.
Patent PT-968039-E (PT)
Inventor: WNUK RALF
IPC: B01D29/15
Filed: 1998-01-21
Abstract: The invention relates to a backwash filtering device using tubular wedge-wired screen elements (8, 42) which can be accommodated in a casing (30) comprising a filter inlet (32) and an outlet (4) for the liquid that is to be filtered. Liquid can flow through the filter elements (8, 42) in both directions for filtering (24) or backwashing (26). An actuatable washing arm (5) is provided for backwashing (26). Said arm has a liquid outlet (52) for contaminated liquid which can be successively displaced underneath the flow-through cross-sections (D) of the filter elements (8, 42). By providing at least part of the tubular wedge-wired screen elements used (8) with a conical design, a backwash device with improved filtering, enhanced backwash capacity and increased energy performance in relation to the liquid flow in said filter elements is thus obtained.
Patent PT-984927-E (PT)
Inventor: SALMON ROGER
IPC: C07C313/04
Filed: 1998-03-04
Abstract: The invention relates to compounds of the formula (I): CF2=CX-CH2-CH2-S(O)-R wherein X represents hydrogen, halogen or lower alkyl, and R represents a group OR1 or NR2R3 wherein R1, R2 and R3 are as defined in the description. The compounds are useful for controlling insect and like pests of agriculture.
Patent PT-983465-E (PT)
Inventor: JARVENKYLA JYRI
IPC: B29C57/04
Filed: 1998-05-21
Abstract: A method for the manufacture of a heat fusion fitting, which comprises i) forming a body ( 1 ) comprising at least a first layer of a first cross-linked polymeric material, ii) embedding or partly embedding a ferromagnetic heating element ( 11, 12 ) in a second polymeric material ( 13, 14 ) to form an insert ( 7, 8 ), the ferromagnetic heating element ( 11, 12 ) having a Curie temperature equal to or greater than the crystalline melting point or softening point of the second polymeric material ( 13, 14 ), and iii) assembling the body and the insert ( 7, 8 ) to form the fitting.
Patent SG-49885-G (SG)
Title: Coin testing apparatus
IPC: G07D/
Filed: 1985-06-24
Abstract: A coin testing apparatus comprises transmitting and receiving coils (14) and (15) on opposite sides of a coin passageway (11). The transmitting coil is connected to high and low frequency oscillators (16) and (17). The output of the receiving coil is separated into the high and low frequency components by a high pass filter (21) and a band pass filter (22). In the high frequency channel the signal is amplitude controlled by a voltage controlled amplifier (23) rectified by a rectifier (24) and smoothed by a long time-constant circuit (26). The initial rise in level caused by a coin entering between the coils (14) and (15) is detected by an instantaneous level change comparator (32) which responds to the rate of change of signal level at the output of the long time-constant circuit (26) becoming equal to preset threshold and causes a normally closed switch (27) to be opened. When the switch (27) is closed a comparator (31) compares the signal with a reference value from a source (30) and adjusts the gain of the amplifier (23) until the signal corresponds to the reference value. Upon the arrival of the coin the switch (27) is opened and a long time-constant circuit (28) causes the gain of the amplifier (23) to be maintained at the level before the arrival of the coin. A window comparator (33) compares the difference in voltage with voltage ranges for acceptable coins. A similar arrangement is provided in the low frequency channel but with two differences. The switch (27) in the low frequency channel is operated by the same instantaneous level comparator as is used for the high frequency channel and instead of a rectifier (24) a novel sample and hold technique is used for providing a d.c. signal from the output of the amplifier (23).
Patent IE-33939-L (IE)
Title: Transistor variable gain circuit
IPC: H03G1/04
Filed: 1970-01-13
Abstract: 1,271,355. Transistor gain control circuits. R.C.A. CORPORATION. 21 Jan., 1970 [29 Jan., 1969], No. 2882/70. Heading H3T. In a transistor gain control circuit the signal is applied at terminal 22 to the base of a transistor 24 acting with resistor 26 as a constant current source and driving a further transistor 12 in common emitter connection. The gain of the arrangement is varied by variation of the base bias of transistor 12, by means of an auxiliary transistor 10 with its collector coupled to the base of transistor 12 and to its own base via a resistor 14 of low value: a gain controlling positive bias is applied to the base of transistor 10 via a resistor 28 of higher value.
[GB1271355A]
Patent IE-860263-L (IE)
Title: Fabric softener composition
IPC: C11D3/00
Filed: 1986-01-30
Abstract: Stable aqueous fabric softening compositions based on water-dispersible cationic fabric softeners such as the di-long chain, di-short chain quaternary ammonium salts are provided using synergistic proportions of fatty alcohols to enhance the softening performance. Both concentrated and ready-for-use formulations can be prepared. The active ingredients concentration in the concentrated formula is generally in the range of 11 to 20% by weight while for the ready-for-use formulations, concentration of the active ingredients may range from about 3 to about 8% by weight. In either case, the weight ratio of cationic softening agent to fatty alcohol being in the range of from about 4.5:1 to 3.5:1. These compositions have low viscosity and are easily dispersible in cold water and are storage stable. Water soluble electrolytes can further reduce viscosity and ethoxylated amines can further increase stability. Methods for making the compositions are also disclosed.
[US4772403A]
Patent IE-840309-L (IE)
Title: Production of protein containing foodstuff from cereals
IPC: A23L7/104
Filed: 1984-02-10
Abstract: Protein foods are made from cereals by (a) milling the cereal and steeping the milled material in water; (b) mechanically separating the mixture from (a) to produce a sediment (I) containing the major proportion of the insoluble material and starch A, and a suspension (II) containing at least 60% of the nitrogeneous material initially present; (c) subsequently separating the suspension (II) to form an insoluble fraction (III) containing at least 60% of the proteins initially present and a supernatant fraction (IV); (d) mixing the sediment (I) with the supernatant fraction (IV) to form a suspension (V) containing at least 90% of the starch initially preset; (e) hydrolyzing the starch in the suspension (V) by addings thermally stable amylase; (f) separating the hydrolysis mixture from stase (e) to provide a supernatant hydrolysate (VI) and an insoluble fraction (VII); (g) fermenting the insoluble fraction (VII) after suspending it in water to cause an enrichment in yeast protein and (h) separating the fermented suspension from (g) into a recyclable effluent and a sediment comprising high grade food protein.
[US4636390A]
Patent IE-780335-L (IE)
Title: Stabilized thymosin fraction 5
IPC: A61P37/00
Filed: 1978-02-16
Abstract: RAN 4090/93 A solid stable endotoxin and pyrogen free form of thymosin fraction 5 preparation containing (a) a major amount of thymosin fraction and minor, effective amounts each of (b) a phenolic type antimicrobial agent, and (c) a buffering agent in an amount sufficient to provide a pH of 7-8 on reconstitution and method for preparing same which method comprises (a) ultrafiltering an aqueous solution of thymosin fraction 5 buffered with a volatile weakly basic buffer to a pH of 7 to 8 through a membrane having a molecular weight cut off of about 10,000, (b) adding a phenolic type antimicrobial agent to the permeate and a buffering agent in anmount sufficient to provide of pH of 7-8 on reconstitution and (c) lyophilizing the permeate.
Patent IE-890589-L (IE)
Title: Novel compounds
IPC: A01N63/50
Filed: 1989-02-24
Abstract: Mutant Bacillus thuringiensis endotoxin proteins, exhibiting the characteristic insecticidal activity shown by the wild type delta -endotoxins. At each individual point of mutation it is indicated that the codons coding for any other natural amino acid can be substituted to produce active endotoxin protein. Also described are DNA sequences encoding such endotoxins and recombinant techniques for the production of insecticidally active mutant endotoxin
[DE3905865A1]
Patent IE-37590-L (IE)
Title: Steering system for articulated vehicle
IPC: B62D7/02
Filed: 1973-05-03
Abstract: 1425604 Articulated vehicles; steering mechanisms E KELLER 9 May 1973 [10 May 1972] 22163/73 Heading B7H An articulated vehicle has front And rear chassis parts 1, 6 which are rotatable relative to an intermediate part 3 about spaced parallel pivot joints 24 by double-acting steering jacks 13, 14 hydraulically connected in series so that extension of one jack is accompanied by contraction of the other. The jacks 13, 14 are identical and each has a differential area piston, the working chambers of smaller cross-section being connected by a flexible hose 19, and the chambers of larger cross-section being connected through control lines 17, 18 to hydrostatic steering control mechanism. An extension member 5 is connected to the rear part 6 by a horizontal pivot joint 7. Stops 20 limit rotation of the front and rear parts 1, 6 relative to the intermediate part 3. Driven axles on the front and rear parts 1,6 are driven through a common gear-box on the intermediate part 3 from an engine on the front part 1, and a dumper skip may be mounted on the rear part 6.
[GB1425604A]
Patent IE-790712-L (IE)
Title: BENZO £b| CYCLOHEPTA £d| PYRAN DERIVATIVES
IPC: C07D311/74
Filed: 1979-08-08
Abstract: {PG,1 Octahydro and hexahydrobenzo{8 b{9 cyclohepta{8 d{9 pyrans having the general formula {r1 {tc,1 {rb {rd,588bbdd003 {a,1 {sd,5 {sb,27 Z{A,2 {500 {A,3 {500 {A,4 {500 {A,5 {500 {A,6 {500 {A,3 {M,1 {A,4 {RD,885 {A,2 {BA,C {SD,5 {SB,20 R{HU 3{A,2 {BN,8 {SD,15 {SB,4 R{HU 3{A,2 {500 {MR,1 {BN,55 {RD,335588BBDD00/246 {500 {A,2 {500 {A,2 {BN,0 {US,5 {SB,4 OR{HU 1{A,3 {500 {A,4 {500 {A,4 {BA,4 {SD,5 {S,5 R{HU 2{A,5 {500 {A,6 {500 {A,6 {BN,B {SD,5 {SB,28 O{RE {PS {PS wherein R{HU 1 {L is hydrogen or alkanoyl, R{HU 2 {L is alkyl or alkenyl, R{HU 3 {L is hydrogen or alkyl, and Z is a two carbon alkylene chain which is substituted or unsubstituted and saturated or unsaturated are provided. Pharmaceutical compositions containing such benzocycloheptapyrans, and a method of treating hypertension are disclosed.
[US4152451A]
Patent IE-32691-L (IE)
Title: Fungicidal compositions
IPC: C07F/
Filed: 1969-07-10
Abstract: 1,239,977. Fungicides containing mixed active ingredients. UCB (UNION CHIMIQUE.-CHEMISCHE BEDRIJVEN) S.A. 11 July, 1969 [12 July, 1968], No. 33332/68. Heading A5E. A fungicidal composition for the protection of plants comprises a triphenyl tin compound and a metal salt of 1, 2-propylene-bis-dithiocarbamic acid (e.g. the Ca, Ba, Sr, Mg, Cu, Fe, Ni, Co, Cd, Zn or Mn salt). The tin compounds may be the chloride, acetate or hydroxide.
[GB1239977A]
Patent IE-830991-L (IE)
Title: Bandages, components thereof and use
IPC: C08G18/78
Filed: 1983-04-29
Abstract: An orthopaedic bandage is described which comprises a support carrying a vinyl compound, which compound polymerises when exposed to a water-activated vinyl polymerisation catalyst, characterised in that the vinyl compound is a hydrophilic prepolymer which contains not less than two polymerisable vinyl groups. Use of a hydrophilic prepolymer which contains not less than two polymerisable vinylic groups results in a storage stable bandage which on exposure to a water activated polymerisation catalyst produces a cast of good strength.
[EP0094222A1]
Patent FI-813802-L (FI)
Inventor: SIWERSSON OLLE LENNART
IPC: B65G67/62
Filed: 1981-11-26
Abstract: Use is made of a screw conveyor to supply and guide bulk material to a belt conveyor of the type having two belts which travel in face-to-face relationship and between which the bulk material is enclosed during conveyance. The screw of the screw conveyor may be rigidly connected to the frame of the belt conveyor and may have its upper end in immediate proximity to the entrance end of the belt conveyor. The tubular outer housing of the screw conveyor is preferably rotatably mounted for rotation about the screw. A material supplying device is provided at the entrance opening of the screw conveyor.
Patent FI-831025-L (FI)
Inventor: DEGRAFF RICHARD RAYMOND
IPC: C07C2/18
Filed: 1983-03-25
Abstract: A mixed propane-propylene feed stream (1) is subjected to catalytic condensation of propylene in a reaction zone (6) to produce C6-plus hydrocarbons. The effluent (7) from the reaction zone (6) is flashed, with the resulting vapour being recycled to the reaction zone, and the remaining liquid (9) is passed into a depropanizer column (10). A C3 sidecut is removed from the column (10) and stripped (17) to separate propylene, which is returned to the column (10), from a high purity propane product (18). The net liquid overhead stream (2) of the column (10) is also recycled to the reaction zone (6). C6-plus hydrocarbons are removed as bottoms from the column (10) and optionally purified in a debutanizer column (13).
Patent IE-811039-L (IE)
Title: Removal of chromium from water
IPC: C02F1/62
Filed: 1981-05-11
Abstract: A continuous process is described, wherein chromium-containing waste waters are subjected to continuous hot treatment with acetic acid or with alkaline acetates and alkaline hydroxides at a temperature from 40 DEG C. to boiling point and at atmospheric pressure, at a pH higher than 6.5, preferably between 7 and 10, particularly about 7.5. Thus, a "sandy" type of chromium hydroxide is obtained, having a titer in Cr2O3 of 20 to 40% by weight, which quickly filters, is easily soluble in acids, and thereby affords an easy valorization both as a tanning agent and as a raw material for preparing other chromium compound.
[US4401573A]
Patent IE-33542-L (IE)
Title: Analgesic compositions
IPC: A61K31/40
Filed: 1969-07-31
Abstract: 1,240,625. Analgesic compositions. ELI LILLY & CO. 14 Aug., 1969 [15 Aug., 1968 (2)], No. 40642/69. Heading A5B. Analgesic compositions comprise (i) a 3- or 4-phenoxyphenylalkanoic acid of the formula: or a pharmaceutically acceptable salt thereof, wherein (a) the phenoxy moiety is in the 3- position and R<SP>3</SP> is methyl or ethyl and R<SP>4</SP> is hydrogen, or (b) the phenoxy moiety is in the 4-position, R<SP>3</SP> is hydrogen or methyl and when R<SP>3</SP> is hydrogen R<SP>4</SP> is hydrogen, fluoro, ethyl, methyl or methoxy and when R<SP>3</SP> is methyl R<SP>4</SP> is hydrogen, and (ii) an ester of 1, 2-diphenyl-2-hydroxy-3-methyl-4-(substituted) aminobutane or a pharmaceutically acceptable salt thereof having the formula: wherein R 1 is methyl or ethyl and R 2 is dimethylamino or pyrrolidino. The composition preferably contains α-d-propoxyphene napsylate or hydrochloride and 2-(3-[or 4]-phenoxyphenyl) propionic acid. The phenoxyphenyl compound may be in the form of the Na, K, Ca, Mg, ammonium or benzylammonium salts and α-d-propoxyphene may be in the form of its hydrochloride, hydrobromide, sulphate, bisulphate, acetate, valerate, oleate, phenate, laurate, borate, benzoate, lactate, phosphate, tosylate, citrate, maleate, fumarate, succinate, tartrate or napsylate. The compositions may be administered orally as tablets, pills, powders, granules, capsules, emulsions, solutions, suspensions, syrups or elixirs; parenterally in the form of sterile aqueous or non-aqueous solutions, suspensions or emulsions; or rectally as suppositories. The compositions may contain additional active ingredients such as acetyl salicylic acid.
[GB1240625A]
Patent IE-811173-L (IE)
Title: Tetrahydroisoquinoline derivatives
IPC: C07D217/08
Filed: 1981-05-26
Abstract: Imidodisulfamide derivatives useful in the treatment of allergic conditions are prepared by reaction of an appropriately substituted tetrahydroisoquinoline and bis (chlorosulfonyl)imide in the presence of a tertiary amine. Pharmaceutical compositions and methods of inhibiting the symptoms of an allergic response are also disclosed.
[US4317826A]
Patent IE-36905-L (IE)
Title: Shirring casings.
IPC: B29C53/30
Filed: 1972-09-22
Abstract: A method and apparatus for shirring sausage casings in which in the method the casing is moved in a direction of its longitudinal axis and while so moving has a force applied to shirr the casing which moves about the longitudinal axis of the casing. At the same time that the force is applied to shirr a force also is applied to oppose the movement of the casing. Also, the casing may be restrained against twisting about its axis upstream of the application of the shirring force. The apparatus includes rollers for forwarding a collapsed casing, an annular element adapted to rotate about the longitudinal axis of the casing to shirr the casing and a backing element adapted to hold the forward end of the casing in a fluid, tight manner and having a passage through which an inflating gas may pass to inflate the casing. The apparatus also may include grooved rollers adapted to hold the inflated casing against rotation prior to shirring and a lubrication device to apply a lubricant or a moistening agent to the casing prior to shirring. The annular element may be a sleeve having a helical projection on the cylindrical inner wall of the sleeve or a unit consisting of a plurality of holders for rotatably mounted wheels which are successively offset from one another so that in the rotation of the annular element they describe the same helical path.
[US3988804A]